Exchange Traded Concepts, LLC Agenus Inc Transaction History

Exchange Traded Concepts, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	BUY	$0.53 - $0.93 $195,098 - $342,343	368,111 Added 343.97%	475,130 $275,000
Q4 2023 Jan 05, 2024	BUY	$0.63 - $1.14 $17,096 - $30,936	27,137 Added 33.97%	107,019 $88,000
Q3 2023 Oct 18, 2023	BUY	$1.12 - $1.88 $8,243 - $13,836	7,360 Added 10.15%	79,882 $90,000
Q2 2023 Jul 20, 2023	BUY	$1.31 - $2.04 $95,003 - $147,944	72,522 New	72,522 $116,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.